Present day therapy of juvenile idiopathic arthritis with the use of genetically engineered medicines in a third level regional hospital - results and problems
Background. Juvenile idiopathic arthritis is accompanied by severe functional disabilities refractory to standard treatment with methotrexate. Recently introduced genetic engineering has significantly improved the functional state of the patients with persistent disease and stopped the progressive d...
Guardado en:
Autores principales: | A. E. Matyunova, L. V. Bregel |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
Scientific Сentre for Family Health and Human Reproduction Problems
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b58c11e40cd94dd5a015953c76545188 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Retrospective analyzes of adverse events during biologic agents in children with juvenile idiopathic arthritis from a single center in Turkey
por: Sibel Balcı, et al.
Publicado: (2020) -
Uveitis associated juvenile idiopathic arthritis – presentation of recently published international recommendations for diagnostic and therapeutic procedures
por: Lidia Rutkowska-Sak, et al.
Publicado: (2020) -
Magnetic resonance imaging of the knee joint in juvenile idiopathic arthritis
por: Emil Michalski, et al.
Publicado: (2020) -
COVID-19 in patients with juvenile idiopathic arthritis: frequency and severity
por: Oksana Boyarchuk, et al.
Publicado: (2021) -
Blood calprotectin in children with juvenile idiopathic arthritis: relationship to flare development after discontinuation of treatment
por: Yaryna Boyko, et al.
Publicado: (2020)